Getinge and TSO3 ends exclusive distribution agreement on low temperature sterilization
Getinge and TSO3 have mutually decided not to renew the exclusive distribution agreement between the two companies, which was initiated in 2015. The agreement ends on August 1, 2018. The impact on the income statement for 2018 is expected to be – 126,4 MSEK mainly related to write-off, and this will be reported as IAC (Items Affecting Comparability). The cash flow for the period will be positively impacted by 70,7 MSEK due to sell-back of inventory to TSO3.Getinge and TSO3 entered into an agreement in 2015, where Getinge aquired exclusive global distribution rights to the STERIZONE VP4